Clinical Significance of Circulating circRNA in Acute Ischemic Stroke (CRAST)
Status: Recruiting
Location: See location...
Intervention Type: Genetic
Study Type: Observational
SUMMARY
CRAST is to analyze the expression pattern of circular RNA (circRNA) by bioinformatics analysis in patients with acute ischemic stroke and healthy control. The candidate circRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Aged 18 years or older
• Confirmed acute ischemic stroke by a diffusion-weighted imaging-position lesion on magnetic resonance imaging (MRI) and a new lesion on a brain computed tomography (CT) scan
• Within 72 hours of symptom onset
• Good performance status
• Signed an approved informed consents
Locations
Other Locations
China
Department of Neurology
RECRUITING
Xuzhou
Contact Information
Primary
Xingzhi Wang, MD
wxz1220@126.com
0086-13852000759
Time Frame
Start Date: 2020-10-01
Estimated Completion Date: 2024-10-30
Participants
Target number of participants: 500
Treatments
AIS group
This group includes patients with acute ischemic stroke (AIS).
HC group
This group includes healthy controls (HC).
Related Therapeutic Areas
Sponsors
Leads: The Affiliated Hospital of Xuzhou Medical University